RNA Interference Therapeutics for Chronic Hepatitis B: Progress, Challenges, and Future Prospects

Abstract excerpt

Chronic hepatitis B (CHB) is a global health challenge that can result in significant liver-related morbidity and mortality. Despite a prophylactic vaccine being available, patients already living with CHB often must engage in lifelong therapy with nucleoside analogues. However, the potential of RNA interference (RNAi) therapeutics as a promising avenue for CHB treatment is being explored. RNAi, particularly...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Hepatitis B Virus Studies
• Share to Immunotherapy and Immune Responses
• Share to RNA Interference and Gene Delivery